← Leaderboards
Abhijit A Date
University Of Illinois At Chicago
$4,064,660
Attributed
$6,876,396
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2022–25$2.5M$1.9M$1.3M$625K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$6,876,396 · 5
By mechanism
R24$4,325,995 · 1
R01$1,297,477 · 1
R21$1,252,924 · 3
Top collaborators
- Deepak Shukla6 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Deepak Shukla$19,733,938
- Divya Rani Bijukumar$239,850
- Kyuyeon Han$1,638,975
- Tejabhiram Yadavalli$1,210,082
Others in their field
Other Rising Stars on “Permeability”
- Heinz Ernst Moser · University Of Texas Med Br Galveston$13,657,841
- Alexander Kolykhalov · Emory University$8,116,465
- Anil Gupta · Scripps Research Institute, The$7,340,144
- Fumiaki Yokokawa · University Of Texas Med Br Galveston$7,180,989
- Sean B. Joseph · Scripps Research Institute, The$4,224,287
- Sarah Elizabeth Lutz · University Of Illinois At Chicago$3,911,564
Research focus
PermeabilityBiological AvailabilityDrug KineticsPharmaceutical PreparationsFormulationMouse ModelOralAnti-Viral EfficacyDoseIn VivoNanoformulationFda ApprovedViral PhysiologySafetyInfectionEvaluationHydrophobicitySaltsCationsFilmBrainAntiretroviral TherapyAcyclovirEye Infections
Grant awards (12)
Alleviation of ER stress as a translational strategy to curb ocular viral infections$1,089,050
R24 · FY2025 · EY
Repurposing and reformulation of adefovir dipivoxil for improved topical treatment of herpes simplex virus infection of the eye$639,940
R01 · FY2025 · EY · contact PI
Ionic liquid-based nanoemulsion containing combination antiretroviral drugs forthe transdermal treatment of pediatric HIV infection$197,763
R21 · FY2025 · AI · contact PI
Ionic liquid-based nanoemulsion containing combination antiretroviral drugs for the oral and transdermal treatment of HIV infection$193,125
R21 · FY2025 · AI · contact PI
Alleviation of ER stress as a translational strategy to curb ocular viral infections$1,094,442
R24 · FY2024 · EY
Repurposing and reformulation of adefovir dipivoxil for improved topical treatment of herpes simplex virus infection of the eye$657,537
R01 · FY2024 · EY · contact PI
Ionic liquid-based nanoemulsion containing combination antiretroviral drugs forthe transdermal treatment of pediatric HIV infection$216,759
R21 · FY2024 · AI · contact PI
Ionic liquid-based nanoemulsion containing combination antiretroviral drugs for the oral and transdermal treatment of HIV infection$208,575
R21 · FY2024 · AI · contact PI
Ionic Liquids of tenofovir prodrugs for improved oral bioavailability and antiviral efficacy$206,452
R21 · FY2024 · AI · contact PI
Alleviation of ER stress as a translational strategy to curb ocular viral infections$1,061,330
R24 · FY2023 · EY
Ionic Liquids of tenofovir prodrugs for improved oral bioavailability and antiviral efficacy$230,250
R21 · FY2023 · AI · contact PI
Alleviation of ER stress as a translational strategy to curb ocular viral infections$1,081,173
R24 · FY2022 · EY